Misconduct versus Honest Error and Scientific Disagreement

Accountability in Research

Volumn 19, Issue 1, 2012, Pages 56-63

  Resnik, David B ^a   Stewart, C Neal ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

ethics; honest error; research misconduct; scientific disagreement

Indexed keywords

EID: 84856940898     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989621.2012.650948     Document Type: Article

References (17)

1. Abramson, S. B. 2011. Differing opinion, not misconduct. Nature, 470: 465
2. DeAngelis, C. D. and Fontanarosa, P. B. 2008. Impugning the integrity of medical science: The adverse effects of industry influence. JAMA, 299: 1833-1835.
3. Fisher, L. D. 1990. "Intention to treat in clinical trials". In Statistical Issues in Drug Research and Development, Edited by: Peace, K. E. 331-350. New York: Marcel Dekker.
4. Gamow, G. 1985. Thirty Years that Shook Physics: The Story of Quantum Theory, New York: Dover.
5. Garamszegi, L. Z. 2009. Changing philosophies and tools for statistical inferences in behavioral ecology. Behavior. Eco., 20: 1363-1375.
6. Gupta, S. K. 2011. Intention-to-treat concept: A review. Persp. Clin. Res., 2: 109-112.
7. Kuhn, T. 1962. The Structure of Scientific Revolutions, Chicago: Univ. of Chicago Press.
8. Morris, E. 2010. Statistics spark dismissal suit. Nature, 467: 260
9. National Academy of Sciences. 2002. "Responsible Science". In The Ensuring Integrity of the Research Process, Vol. 1, Washington, D.C: National Academy Press.
10. Natural Sciences and Engineering Research Council of Canada. (2006). Tri-Council policy statement: Integrity in research and scholarship. http://www.nserc-crsng.gc.ca/NSERC-CRSNG/policies-politiques/tpsintegrity-picintegritie_eng.asp (http://www.nserc-crsng.gc.ca/NSERC-CRSNG/policies-politiques/tpsintegrity-picintegritie_eng.asp) (Accessed: 3 January 2012).
11. Office of Science and Technology Policy. 2000. Federal Research Misconduct Policy. Federal Register, 65: 76262
12. Psaty, B. M. and Kronmal, R. A. 2008. Reporting mortality findings in trials of tofecoxib for Alzheimer disease or cognitive impairment: A case study based on documents from rofecoxib litigation. JAMA, 299: 1813-1817.
13. Resnik, D. B. 2003. From Baltimore to Bell Labs: Reflections on two decades of debate about scientific misconduct. Accountability in Research, 10: 123-125.
14. Shamoo, A. S. and Resnik, D. B. 2009. "Responsible Conduct of Research". In, 2nd, New York: Oxford Univ. Press.
15. Wellcome Trust. (2005). Statement on the handling of allegations of research misconduct. http://www.wellcome.ac.uk/About-us/Policy/Policy-and-position-statements/WTD002756.htm (http://www.wellcome.ac.uk/About-us/Policy/Policy-and-position-statements/WTD002756.htm) (Accessed: 3 January 2012).
16. Yuan, J. S., Reed, A., Chen, F. and Stewart, C. N. Jr. 2006. Statistical analysis of real-time PCR data. BMC Bioinformatics, 7: 85
17. Yuan, J. S., Wang, D. and Stewart, C. N. Jr. 2008. Statistical methods for efficiency adjusted real-time PCR analysis. Biotechnol. J., 3: 112-123.